These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28190390)

  • 1. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics.
    Lu DY; Qu RX; Lu TR; Wu HY
    Rev Recent Clin Trials; 2017; 12(2):101-110. PubMed ID: 28190390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
    Albin N; Mc Leer A; Sakhri L
    Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Combination in Clinical Cancer Treatments.
    Lu DY; Lu TR; Yarla NS; Wu HY; Xu B; Ding J; Zhu H
    Rev Recent Clin Trials; 2017; 12(3):202-211. PubMed ID: 28782482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Drug Combinations, How Far We can Go Through?
    Lu DY; Chen EH; Wu HY; Lu TR; Xu B; Ding J
    Anticancer Agents Med Chem; 2017; 17(1):21-28. PubMed ID: 27039923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of bioinformatics in personalised medicine].
    Lengauer T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1489-94. PubMed ID: 24170077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonotyping for precision oncology.
    Dang HX; Maher CA
    Drug Discov Today; 2015 Dec; 20(12):1464-9. PubMed ID: 26494143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioinformatics in Cancer Clinical Sequencing -- An Emerging Field of Cancer Personalized Medicine].
    Kato M
    Gan To Kagaku Ryoho; 2016 Apr; 43(4):391-7. PubMed ID: 27220783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Cancer: Genetics and the Role of Precision Medicine.
    Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
    Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative methods for analyzing big data in precision medicine.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.
    Banwait JK; Bastola DR
    Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 13. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs.
    Buzdin A; Sorokin M; Garazha A; Sekacheva M; Kim E; Zhukov N; Wang Y; Li X; Kar S; Hartmann C; Samii A; Giese A; Borisov N
    Semin Cancer Biol; 2018 Dec; 53():110-124. PubMed ID: 29935311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine.
    Shinko D; Diakos CI; Clarke SJ; Charles KA
    Clin Pharmacol Ther; 2017 Oct; 102(4):599-610. PubMed ID: 28699186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and bioinformatics as pillars of precision medicine in oncology.
    Canzoneri R; Lacunza E; Abba MC
    Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successes and limitations of targeted cancer therapy in breast cancer.
    Curigliano G; Criscitiello C
    Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.
    Bryce AH; Egan JB; Borad MJ; Stewart AK; Nowakowski GS; Chanan-Khan A; Patnaik MM; Ansell SM; Banck MS; Robinson SI; Mansfield AS; Klee EW; Oliver GR; McCormick JB; Huneke NE; Tagtow CM; Jenkins RB; Rumilla KM; Kerr SE; Kocher JA; Beck SA; Fernandez-Zapico ME; Farrugia G; Lazaridis KN; McWilliams RR
    Oncotarget; 2017 Apr; 8(16):27145-27154. PubMed ID: 28423702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Precision medicine from experimental to clinical applications in oncology].
    Normanno N
    Recenti Prog Med; 2015 Dec; 106(12):597-600. PubMed ID: 26780068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
    Tsimberidou AM; Ringborg U; Schilsky RL
    Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.